TG Therapeutics | TGTX - Spese Operative





Spese Operative Cambiamento Data
AbbVie USD 10.81B 13.45B 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Amgen USD 5.9B 773M 2025-12
Ardelyx USD 120.12M 14.46M 2025-12
Arrowhead Research USD 223.22M 10.86M 2025-12
Bayer EUR 10.33B 126M 2025-12
Biogen USD 1.88B 81.4M 2025-09
Corcept Therapeutics USD 197.64M 219K 2025-12
Curis USD 9.02M 23.01M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Infinity Pharmaceuticals USD 10.7M 1.54M 2023-06
J&J USD 17.44B 1.53B 2026-03
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Novartis USD 9.8B 61M 2025-12
Novavax USD 126.2M 23.62M 2025-12
PTC Therapeutics USD 246.3M 38.78M 2025-12
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
TG Therapeutics USD 142.08M 9.74M 2025-12
Verastem USD 59.01M 21.98M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12